Related references
Note: Only part of the references are listed.SPF45/RBM17-dependent, but not U2AF-dependent, splicing in a distinct subset of human short introns
Kazuhiro Fukumura et al.
NATURE COMMUNICATIONS (2021)
The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
Betty Y. Tam et al.
CANCER LETTERS (2020)
Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1
Dehuan Ji et al.
ONCOGENE (2020)
RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid Leukemia
Govardhan Anande et al.
CLINICAL CANCER RESEARCH (2020)
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Eric Wang et al.
CANCER CELL (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
Ying Ge et al.
NATURE COMMUNICATIONS (2019)
eIF4A2 drives repression of translation at initiation by Ccr4-Not through purine-rich motifs in the 5′UTR
Ania Wilczynska et al.
GENOME BIOLOGY (2019)
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
Brett M. Stevens et al.
NATURE COMMUNICATIONS (2018)
Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells
Aditi Shastri et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
RBM17 Interacts with U2SURP and CHERP to Regulate Expression and Splicing of RNA-Processing Proteins
Antonia De Maio et al.
CELL REPORTS (2018)
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Simon Raffel et al.
NATURE (2017)
RNA-Binding Proteins in Cancer: Old Players and New Actors
Bruno Pereira et al.
TRENDS IN CANCER (2017)
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
Eric R. Lechman et al.
CANCER CELL (2016)
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
Leslie A. Crews et al.
CELL STEM CELL (2016)
A 17-gene stemness score for rapid determination of risk in acute leukaemia
Stanley W. K. Ng et al.
NATURE (2016)
Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)
Eric L. Van Nostrand et al.
NATURE METHODS (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias
Vincent-Philippe Lavallee et al.
NATURE GENETICS (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis
Namyoung Jung et al.
NATURE COMMUNICATIONS (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
Nicolas Rapin et al.
BLOOD (2014)
Structural Changes Enable Start Codon Recognition by the Eukaryotic Translation Initiation Complex
Tanweer Hussain et al.
CELL (2014)
Alternative Splicing of MBD2 Supports Self-Renewal in Human Pluripotent Stem Cells
Yu Lu et al.
CELL STEM CELL (2014)
A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets
Sophia Adamia et al.
CLINICAL CANCER RESEARCH (2014)
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity
K. P. Callahan et al.
LEUKEMIA (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
Evidence for a Functionally Relevant Rocaglamide Binding Site on the eIF4A-RNA Complex
Heather Sadlish et al.
ACS CHEMICAL BIOLOGY (2013)
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
S. N. Khan et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Phosphorylation of the alternative mRNA splicing factor 45 (SPF45) by Clk1 regulates its splice site utilization, cell migration and invasion
Yuying Liu et al.
NUCLEIC ACIDS RESEARCH (2013)
EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
Lilian E. van Vlerken et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
Satomi Tanaka et al.
BLOOD (2012)
Mitogen-Activated Protein Kinase Phosphorylation of Splicing Factor 45 (SPF45) Regulates SPF45 Alternative Splicing Site Utilization, Proliferation, and Cell Adhesion
Adnan M. Al-Ayoubi et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
Oleg Fedorov et al.
CHEMISTRY & BIOLOGY (2011)
REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
Fran Supek et al.
PLOS ONE (2011)
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
Torsten Haferlach et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches
Mo Chen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation
Annelie E. Abrahamsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells
Ravindra Majetl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells:: A mechanistic difference between normal and cancer stem cells
Oemer H. Yilmaz et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
Alexander Kohlmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
The birth of new exons: Mechanisms and evolutionary consequences
Rotem Sorek
RNA (2007)
Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay
Julie Z. Ni et al.
GENES & DEVELOPMENT (2007)
Opinion - The origin of the cancer stem cell: current controversies and new insights
R Bjerkvig et al.
NATURE REVIEWS CANCER (2005)
Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed -: a phenotype partially reversed by selective estrogen receptor modulators
WL Perry et al.
CANCER RESEARCH (2005)
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters
M Amendola et al.
NATURE BIOTECHNOLOGY (2005)
Antisense abrogation of DENN expression induces apoptosis of leukemia cells in vitro, causes tumor regression in vivo and alters the transcription of genes involved in apoptosis and the cell cycle
KM Lim et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
How prevalent is functional alternative splicing in the human genome?
R Sorek et al.
TRENDS IN GENETICS (2004)
Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells
J Sampath et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Splicing regulation at the second catalytic step by sex-lethal involves 3′ splice site recognition by SPF45
MJ Lallena et al.
CELL (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Share Paper
